Substance/Alcohol Use disorders are defined as a loss of control over the use despite harmul consequences, as well as an intense and persistent urge to use, also called craving. Previous research has shown that craving is central among the diagnostic criteria for addiction, suggesting that it may be important in the onset and persistence of addiction. Addiction develops progressively, and it appears crucial to identify predictive markers of the transition from one level of severity to another over time. One hypothesis is that more closely linked symptoms (meaning symptoms that influence each other more) could be associated with greater severity and/or with the evolution of addiction severity over time. The aim of this project is to explore how the characteristics of the association between addiction symptoms (diagnostic criteria and symptoms as they occur in daily life), and the importance of craving relative to other symptoms, could serve as markers of different addiction severities and of the transition across these levels of severity.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Craving centrality in the DSM-5 Substance Use Disorder diagnostic criteria network
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Global connectivity of the DSM-5 Substance Use Disorder diagnostic criteria network
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Predictability of nodes in the DSM-5 Substance Use Disorder diagnostic criteria network
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Differences in DSM-5 Substance Use Disorder diagnostic criteria network structure
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Temporal network structure of ecological momentary assessment (EMA) symptoms
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Contemporaneous network structure of ecological momentary assessment (EMA) symptoms
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Between-subject network structure of ecological momentary assessment (EMA) symptoms
Timeframe: Baseline, 1-year follow-up, 2-year follow-up
Individual network invariance assessed by the Individual Network Invariance Test (INIT)
Timeframe: Baseline, 1-year follow-up, 2-year follow-up